Yann Chong Tan

Yann Chong Tan is currently the Co-founder and Chief Executive Officer at Nuevocor, and previously held the position of Co-founder and Chief Scientific Officer at Cargene Therapeutics. Prior to these roles, Yann Chong Tan served as Managing Director and Vice President at EVX Ventures. With a background in immunology, Yann Chong Tan is also known for their contribution as Chief Innovation Officer at the Genome Institute of Singapore and as Chief Technologist and Co-founder at Atreca, Inc., a company founded from their PhD thesis work. Yann Chong Tan holds a Ph.D. in Immunology from Stanford University and a Bachelor of Science in Biology from Duke University.